AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Knowing when to assess your retirement strategy ensures your financial plan remains effective. Regular evaluations can lead to better outcomes.
21,973 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Gulf sovereign wealth funds accelerate dealmaking in 2026, defying fears that the Iran conflict would curb appetite f...
Two Roundhill ETFs harness a 0DTE covered call strategy to deliver regular Friday payouts, but investors should weigh...
A growing share of veterans aging in place face repairs and accessibility gaps that threaten stable housing. Experts ...
YieldMax’s Ultra Option Income Strategy ETF (ULTY) keeps paying weekly, but volatility is the fuel and risk. This rep...
In 2026, the iMGP DBi Managed Futures Strategy ETF (DBMF) is delivering an 11% year-to-date gain against a roughly 5%...
Lucid delivered higher volumes and nudged toward improving efficiency, signaling a potential turn in its long EV jour...
A morning surge in AeroVironment stock popped today after reports of potential U.S. drone subsidies. This guide unpac...
Could Penguin Solutions be the next stock to deliver outsized gains? This article breaks down the growth engines, pot...
Hims Hers Health shares jumped after news of a Novo Nordisk collaboration. This guide breaks down what the deal could...
SentinelOne stock sinking today has investors weighing earnings quality against growth potential. This article breaks...
OpenAI is stepping up its defense against prompt injection with a new AI red team. This shift could reshape how crypt...